Oksikodon Lek 20 mg tablete s podaljšanim sproščanjem Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oksikodon lek 20 mg tablete s podaljšanim sproščanjem

lek d.d. - oksikodon - tableta s podaljšanim sproščanjem - oksikodon 17,9 mg / 1 tableta - oksikodon

Oksikodon Lek 40 mg tablete s podaljšanim sproščanjem Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oksikodon lek 40 mg tablete s podaljšanim sproščanjem

lek d.d. - oksikodon - tableta s podaljšanim sproščanjem - oksikodon 35,9 mg / 1 tableta - oksikodon

Oksikodon Lek 80 mg tablete s podaljšanim sproščanjem Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oksikodon lek 80 mg tablete s podaljšanim sproščanjem

lek d.d. - oksikodon - tableta s podaljšanim sproščanjem - oksikodon 71,7 mg / 1 tableta - oksikodon

Byooviz Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ximluci Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Nevanac Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmologi - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

FOSAMAX enkrat tedensko 70 mg tablete Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fosamax enkrat tedensko 70 mg tablete

merck sharp & dohme, d.o.o. - alendronska kislina - tableta - alendronska kislina 70 mg / 1 tableta - alendronska kislina

Actonel enkrat tedensko 35 mg filmsko obložene tablete Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actonel enkrat tedensko 35 mg filmsko obložene tablete

filmsko obložena tableta - risedronska kislina

Firazyr Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - ikatibant - angioedem, dedno - srčna terapija - zdravilo firazyr je indicirano za simptomatsko zdravljenje akutnih napadov dednega angioedema (hae) pri odraslih (s pomanjkanjem inhibitorja c1-esteraze).

Ruconest Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

ruconest

pharming group n.v. - rekombinantne človeške c1-inhibitor - angioedem, dedno - drugs used in hereditary angioedema, other hematological agents - zdravilo ruconest je indicirano za zdravljenje akutnih napadov angioedem pri odraslih z dednim angioedemom (hae) zaradi pomanjkanja inhibitorja c1-esteraze.